Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population CellsMiho Nara(Akita University), Hiroyuki Tagawa(Akita University)PLoS ONEMarch 4, 201310.1371/journal.pone.0056954Cited by 56SaveCiteExport RISWatch citationsRelated PapersHypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma|Cancer Science|2020|57Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma|Oncotarget|2016|35